| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9683 |
| Human Intestinal Absorption | HIA+ | 0.9476 |
| Caco-2 Permeability | Caco2- | 0.5126 |
| P-glycoprotein Substrate | Substrate | 0.7862 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8563 |
| Inhibitor | 0.7689 |
| Renal Organic Cation Transporter | Inhibitor | 0.5807 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6061 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7442 |
| CYP450 2D6 Substrate | Substrate | 0.8919 |
| CYP450 3A4 Substrate | Non-substrate | 0.6813 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9107 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.9278 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9089 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7548 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7745 |
| Inhibitor | 0.7066 |
| AMES Toxicity | Non AMES toxic | 0.8093 |
| Carcinogens | Non-carcinogens | 0.8836 |
| Fish Toxicity | High FHMT | 0.8792 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9544 |
| Honey Bee Toxicity | Low HBT | 0.8178 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | II | 0.7409 |
| Carcinogenicity (Three-class) | Non-required | 0.6843 |